Related Experiment Video
Updated: Jul 21, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Contemporary thinking for congenital heart disease.
1Inova Fairfax Hospital for Children, Fairfax, VA, USA.
Pediatric Nursing
|September 11, 2003
Summary
Pediatric nurses can better care for children with congenital heart disease (CHD) by categorizing them into three physiologic groups. This approach guides interventions for increased pulmonary blood flow, decreased pulmonary blood flow, and obstructed systemic blood flow.
Area of Science:
- Pediatric Nursing
- Pediatric Cardiology
- Congenital Heart Disease Pathophysiology
Background:
- Traditional classification of congenital heart disease (CHD) into cyanotic and acyanotic defects offers limited practical guidance for pediatric nurses.
- Effective management of pediatric patients with CHD requires a framework that directly informs clinical interventions.
Observation:
- Children with CHD can be categorized based on three primary physiologic derangements: increased pulmonary blood flow, decreased pulmonary blood flow, or obstruction to systemic blood flow.
- Each category presents distinct clinical challenges and necessitates specific management strategies.
Findings:
- Increased pulmonary blood flow necessitates management of congestive heart failure (CHF) symptoms, including medication, nutritional support, and coordinated care.
- Decreased pulmonary blood flow requires surgical intervention to establish adequate pulmonary circulation.
- Obstruction to systemic blood flow demands interventions for both CHF symptoms and impaired ventricular contractility.
Implications:
- Reclassifying CHD based on physiology enhances pediatric nurses' ability to plan and implement effective care.
- This physiologic approach provides a more practical and actionable understanding for managing complex pediatric cardiac conditions.
- Improved understanding and categorization of CHD can lead to better patient outcomes and more efficient healthcare delivery.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...